Huntsman (HUN)
(Delayed Data from NYSE)
$23.41 USD
+0.34 (1.47%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $23.42 +0.01 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Huntsman Corporation [HUN]
Reports for Purchase
Showing records 61 - 80 ( 466 total )
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
3Q Follow Up - Tough to Judge True Run Rate with Sub-Trend 4Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
3Q22 First Look - 4Q Guide Pointing to ~48% Q/Q Decline
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Chemicals: 3Q22 Preview - Estimates Could Sink to Trough Levels by Year-End
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
NDR Takeaways - Facing Tough Times in Strong Fighting Shape
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Textiles Effects Sale Positive for Portfolio
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
2Q22 First Look - Strong 2Q but 3Q Guide Below Consensus
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
2Q22 Follow Up - Key Margins Weaken in 2H, to Test Where Trough Is
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department